Literature DB >> 8524214

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

R R Beerli1, D Graus-Porta, K Woods-Cook, X Chen, Y Yarden, N E Hynes.   

Abstract

Neu differentiation factor (NDF)-induced signaling involves the activation of members of the ErbB family of receptor tyrosine kinases. Although ectopic expression of recombinant ErbB receptors has yielded valuable insight into their signaling properties, the biological function and in vivo interplay of these receptors are still poorly understood. We addressed this issue by studying NDF signaling in various human cell lines expressing moderate levels of all known ErbB receptors. NDF-induced phosphorylation of ErbB-2 and ErbB-3 was found in the breast epithelial cell line MCF10A, the breast tumor cell lines T47D and MCF7, and the ovarian tumor cell line OVCAR3. Despite similar expression levels, NDF-induced phosphorylation of ErbB-4 was cell specific and only detected in T47D and OVCAR3 cells. Blocking cell surface expression of ErbB-2 by intracellular expression of a single-chain antibody revealed that in these two cell lines, ErbB-2 significantly enhanced phosphorylation of ErbB-4. Efficient NDF-induced phosphorylation of ErbB-3 was strictly ErbB-2 dependent in the breast tumor cell lines T47D and MCF7, while it was largely ErbB-2 independent in MCF10A and OVCAR3 cells. Consequently, NDF-stimulated intracellular signaling and induction of a biological response displayed a cell-specific requirement for ErbB-2. Thus, while ErbB-2 cooperates with NDF receptors in the breast tumor cell lines, ErbB-2 independent mechanisms seem to prevail in other cellular contexts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524214      PMCID: PMC230902          DOI: 10.1128/MCB.15.12.6496

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  62 in total

Review 1.  Oncogenes, growth factors, and signal transduction.

Authors:  B J Druker; H J Mamon; T M Roberts
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

2.  Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.

Authors:  C Ellis; M Moran; F McCormick; T Pawson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

Review 3.  Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.

Authors:  W J Gullick
Journal:  Br Med Bull       Date:  1991-01       Impact factor: 4.291

4.  Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.

Authors:  T Wada; X L Qian; M I Greene
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

Authors:  H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

6.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

7.  Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

Authors:  G D Plowman; G S Whitney; M G Neubauer; J M Green; V L McDonald; G J Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Overexpression of the c-erbB-2 protein in human breast tumor cell lines.

Authors:  N E Hynes; H A Gerber; S Saurer; B Groner
Journal:  J Cell Biochem       Date:  1989-02       Impact factor: 4.429

9.  Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

Authors:  M H Kraus; W Issing; T Miki; N C Popescu; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.

Authors:  C R King; I Borrello; F Bellot; P Comoglio; J Schlessinger
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  52 in total

Review 1.  Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland.

Authors:  K L Carraway; C A Carraway; K L Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 2.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 3.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

4.  Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.

Authors:  S Stoll; W Garner; J Elder
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.

Authors:  D Graus-Porta; R R Beerli; J M Daly; N E Hynes
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 6.  Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.

Authors:  Edwin Li; Kalina Hristova
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

7.  Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells.

Authors:  Kathleen M Woods Ignatoski; Michele L Dziubinski; Cheryl Ammerman; Stephen P Ethier
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

8.  ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.

Authors:  M A Olayioye; D Graus-Porta; R R Beerli; J Rohrer; B Gay; N E Hynes
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland.

Authors:  Ilkka Paatero; Tiffany N Seagroves; Katri Vaparanta; Wen Han; Frank E Jones; Randall S Johnson; Klaus Elenius
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

10.  Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.

Authors:  Daniel J Barr; Anne G Ostermeyer-Fay; Rachel A Matundan; Deborah A Brown
Journal:  J Cell Sci       Date:  2008-09-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.